Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Future Market Size Estimation For The Renal Denervation Devices Market Covering 2025–2034?
The overall market valuation for renal denervation devices has experienced a dramatic escalation recently, set to expand from half a billion dollars plus ($0.55 billion) in 2024 to $0.74 billion by the following year, reflecting a robust compound annual growth rate (CAGR) of 33.1%. This significant historical expansion is fundamentally fueled by a rise in hypertension occurrences, ongoing clinical investigations and accumulated research findings, the growing prevalence of cardiovascular ailments, the issuance of initial FDA clearances and associated regulatory advancements, alongside the introduction of new renal denervation technologies into the marketplace.
Anticipated within the coming years is substantial, even explosive, expansion for the market encompassing renal denervation devices, projecting a valuation of $2.27 billion by 2029, propelled by a cumulative annual growth rate (CAGR) of 32.5%; this upsurge during the projection timeline is attributable to several factors, including a heightened focus on the patient, advancements in healthcare infrastructure, broadening awareness and adoption, a clear preference for less invasive treatment modalities, and the introduction of novel devices into the marketplace.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10631&type=smp
What Are The Key Drivers Of Growth In The Renal Denervation Devices Market?
Anticipated expansion in the frequency of hypertension is set to fuel the expansion of the renal denervation devices market in the coming period. High blood pressure, medically termed hypertension, describes an ailment where the pressure exerted by circulating blood against vessel walls remains chronically elevated. Renal denervation has surfaced as a promising interventional strategy, involving a catheter-based technique, particularly beneficial for individuals suffering from hypertension resistant to drug therapies; this minimally invasive, still officially investigational technique aims to manage blood pressure unresponsive to pharmaceuticals. To illustrate the scale of the issue, data released by the US government agency, the Centers for Disease Control and Prevention, in May 2024, indicated that in 2022, high blood pressure was either a direct cause or a contributing factor to 685,875 fatalities across the United States. Consequently, the rising incidence of hypertension will act as a catalyst for the advancement of the market for renal denervation equipment.
What Are The Primary Types Of Segments Analyzed In The Renal Denervation Devices Market?
The renal denervation devicesmarket covered in this report is segmented –
1) By Product: Simplicity Renal Denervation System, EnligHTN, Vessix Renal Denervation System, Iberis Renal Sympathetic Denervation System, Paradise Renal Denervation System, Other Products
2) By Technology: Radio Frequency Ablation, Ultrasound Energy-Based RDN, Brachytherapy, Chemical Ablation, Other Technologies
3) By End-Users: Hospitals, Cardiovascular research centre, Other End-Users
Subsegments:
1) By Simplicity Renal Denervation System: Catheter System, Accessories
2) By EnligHTN: Catheter System, Generator, Accessories
3) By Vessix Renal Denervation System: Balloon Catheter, Generator, Accessories
4) By Iberis Renal Sympathetic Denervation System: Catheter System, Accessories
5) By Paradise Renal Denervation System: Catheter System, Accessories
6) By Other Products: Emerging Technologies, Alternative Devices
What Trends Are Expected To Drive The Renal Denervation Devices Market?
The principal entities actively participating in the renal denervation devices sector are directing their efforts toward innovating ultrasound renal denervation (uRDN) with the goal of making treatments more effective, minimizing issues arising from procedures, and establishing a less invasive option compared to established renal denervation methods. Ultrasound renal denervation (uRDN) elevates the standard of renal denervation apparatus by allowing exact, non-intrusive energy application targeting the renal nerves, which successfully brings down blood pressure while simultaneously safeguarding adjacent structures, thereby boosting procedural safety and patient ease. A prime illustration of this trend is Recor Medical Inc., a US medical technology firm, which introduced its Paradise uRDN system in November 2023; this novel ultrasound renal denervation instrument is specifically engineered to manage hypertension in individuals whose blood pressure remains uncontrolled despite adhering to conventional medication and lifestyle adjustments. Distinguished by its incorporation of hydrocooling mechanisms intended to shield the renal artery throughout the therapeutic intervention, this system marks a substantial progression within the renal denervation device arena by presenting a novel, non-drug-based strategy for handling refractory hypertension, consequently broadening treatment accessibility for those in need.
Who Are The Top Performing Companies In The Renal Denervation Devices Market In Recent Years?
Major companies operating in the renal denervation devices market include Medtronic PLC, ReCor Medical Inc., Boston Scientific Corporation, Abbott Laboratories, Cordis Corporation, Terumo Corporation, Kona Medical Inc., St. Jude Medical LLC, Johnson & Johnson, Mercator MedSystems Inc., Symple Surgical Inc., Ablative Solutions Inc., Cardiosonic Ltd., Renal Dynamics Ltd., Vesalio LLC, Atricure Inc., Biosense Webster Inc., Biotronik SE & Co. KG, Cook Medical LLC, Hansen Medical Inc., Merit Medical Systems Inc., AngioDynamics Inc., Covidien Ltd., Volcano Corporation, Edwards Lifesciences Corporation, InnoVein Inc., Teleflex Incorporated, Medinol Ltd., Oscor Inc., Balton Sp. z o.o.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/renal-denervation-devices-global-market-report
How Do Regional Market Performances Compare Within The Renal Denervation Devices Industry?
Europe was the largest region in the renal denervation devices market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global renal denervation devices market report during the forecast period. The regions covered in the renal denervation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Renal Denervation Devices Market Report:
https://www.thebusinessresearchcompany.com/customise?id=10631&type=smp
Browse Through More Reports Similar to the Global Renal Denervation Devices Market 2025, By The Business Research Company
Blood Pressure Monitoring Devices Global Market Report 2025
Wearable Blood Pressure Monitors Global Market Report 2025
Pulmonary Arterial Hypertension Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model